Latest News

CIMT

Riikka CIMT

Head of R&D Riikka Havunen was awarded oral presentation “Oncolytic adenoviruses armed with tumor necrosis factor alpha and interleukin-2 enable treatment of solid tumors with T cell therapies” at the 16th Cancer Immunotherapy Annual Meeting in Mainz, Germany in May 2018.

Poster of the presentation was also presented in the meeting.

Latest News

Upcoming Events

Please contact our business development team to meet us at the following events:

7-9th December 2022
Geneva, Switzerland
20-22nd March 2023
Basel, Switzerland
15–16th May 2023
Dublin, Ireland
5-8th June 2023
Boston (MA), USA
2-6th June 2023
Chicago (IL), USA